Therapeutic Area

Psychiatry

CNS and neuropsychiatric clinical research — depression, schizophrenia, anxiety, and neurodegeneration studies, managed with validated scale administration and specialist investigator oversight.

Initiate a Psychiatry Trial

Overview

CNS Research, Structured for Complexity.

Mayomi Research Solutions manages psychiatry and central nervous system (CNS) clinical trials across major depressive disorder, treatment-resistant depression, schizophrenia, bipolar disorder, anxiety disorders, ADHD, and neurodegenerative conditions including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Our team is trained in the unique operational demands of CNS trials, including rater training, scale standardisation, and blinding maintenance.

We provide specialist support for validated psychiatric scale administration including PANSS, HAMD-17, MADRS, YBOCS, and CGI, as well as neuropsychological assessment battery coordination, cognitive endpoint tracking, and safety monitoring for CNS-active agents.

Major depressive disorder & TRD antidepressant trials
Schizophrenia & first-episode psychosis studies
Anxiety, OCD & PTSD pharmacotherapy trials
Alzheimer's & Parkinson's disease management research
ADHD & paediatric CNS development studies

At a Glance

Trial Phases Phase II, III, IV

Regulatory Bodies CDSCO, FDA, EMA, ICMR

Key Endpoints PANSS, HAMD-17, MADRS, MMSE, ADAS-Cog, CGI

Patient Population Adults 18+, elderly (Alzheimer's), paediatric (ADHD)

Study Types RCT, DB placebo-controlled, open-label

Location Bengaluru, Psychiatric hospitals & neurology centres

Trial Capabilities

What We Deliver.

Specialized capabilities built for the unique demands of psychiatry and CNS clinical research.

Depression & Anxiety Studies

Full management of antidepressant and anxiolytic trials with validated HAMD-17, MADRS, GAD-7, and PHQ-9 scale administration, rater training, and inter-rater reliability monitoring.

PANSS / HAMD Scale Scoring

Centralised rater certification and scale scoring quality oversight for PANSS, HAMD, MADRS, BPRS, and AIMS — ensuring endpoint consistency and regulatory acceptability of CNS data.

Neurodegeneration Protocols

Expert coordination of Alzheimer's, Parkinson's, and MS clinical trials including cognitive assessment battery scheduling, caregiver diary management, neuroimaging coordination, and long-term safety follow-up.